We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First International Guidelines Issued for Echocardiographic Diagnosis of Rheumatic Heart Disease

By MedImaging International staff writers
Posted on 13 Mar 2012
New international guidelines have been established for the diagnosis of rheumatic heart disease (RHD), a disease that affects millions of people worldwide. The guidelines define the minimum requirements needed to diagnose RHD in individuals without a clear history of acute rheumatic fever (ARF), and will have important both global and national implications.

The guidelines were published March 1, 2012, by the World Heart Federation (Geneva, Switzerland) in the journal Nature Reviews Cardiology. Diagnosis is conducted with an ultrasound of the heart’s valves and chambers, known as an echocardiogram, but currently no guidelines are available to clarify what is normal on echocardiography.

In the absence of definitive guidance, physicians reporting on echocardiograms make decisions based on their clinical experience, and missing the disease at an early stage can have devastating consequences. “The new evidence-based guidelines clearly define not only what is considered to be a definite and a borderline case of RHD but also what is considered normal in children,” said Dr Bo Reményi, Menzies School of Health Research (Darwin, NT, Australia). “The aim of the guidelines is to maximize pick-up of minor degrees of RHD, while preventing over-diagnosis.”

The World Heart Federation echocardiographic criteria for RHD have been developed and formulated on the basis of the best available evidence. “The use of the guidelines should enable rapid identification of RHD patients who do not have a history of ARF,” said Prof. Jonathan Carapetis, a coauthor of the guidelines and Director of the Menzies School of Health Research in Darwin (NT, Australia).

Dr. Nigel Wilson a coauthor and pediatric cardiologist from the Starship Children’s Hospital, (Auckland, New Zealand), commented that, “the guidelines should also allow for consistent echocardiographic reporting of RHD worldwide, which will in turn help us to get a better understanding of the number of people that are truly affected by this disease.”

Three categories have been defined based on assessment by 2D, continuous-wave, and color-Doppler echocardiography: definite RHD, borderline RHD, and normal. Four subcategories of definite RHD and three subcategories of borderline RHD exist, to reflect the various disease patterns.

Related Links:

World Heart Federation

Breast Localization System
MAMMOREP LOOP
Ultrasound Needle Guidance System
SonoSite L25
Half Apron
Demi
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.